Latest News
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
Latest News
Screening Identifies Familial Risk for Hereditary Breast and Ovarian Cancer in Large Health System
The number needed to test to detect one BRCA1/2-positive patient decreased from 128 to 53 for women and from 119 to 42 for men when prescreening...
Feature
FDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering Concerns
Clinical laboratory lobbying groups are suing the FDA over its plans to more strictly regulate lab-developed tests. For now, physicians should see...
Latest News
Doulas Support Moms-to-Be and Try to Fit Into the Obstetric Care Team
For now, mothers who can afford or access doula care are disproportionately White, and the doulas serving them tend to be of the same race and...
Latest News
Does Preconception BMI Affect Time to Pregnancy and Miscarriage Risk?
BMI outside of the normal category in women and men was associated with lower fecundability, subfertility, and increased odds of miscarriage.
Latest News
Dealing with Hot Flashes? Try Hypnosis
Hypnosis can address the “perfect storm” of mental and physical issues that come with menopause symptoms.
Latest News
She Was Accused of Murder After Losing Her Pregnancy. SC Woman Now Tells Her Story
“The Dobbs decision unleashed and empowered prosecutors to look at pregnant people as a suspect class and at pregnancy loss as a...
Latest News
Elinzanetant Shows Significant Improvement in Menopausal Vasomotor and Sleep Symptoms
The women who are the best candidates for elinzanetant include those who have had an estrogen-sensitive cancer, such as breast or endometrial...
From the Journals
Black Women Have a Higher Risk for Death in BC Subtypes
Researchers examined racial differences in BC survival by subtype through conducting a systematic review and meta-analysis of 18 US studies.
News from the FDA/CDC
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
The FDA also approved ribociclib and the aromatase inhibitor letrozole packaged together for the same indication.